Oppenheimer holds a conference call with CEO Friedman, CMO Taub, CFO Howarth and CCO Sukhija on September 26 at 11 am.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on MDGL:
- Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- Hold Rating Maintained for Madrigal Pharmaceuticals Amidst Leadership Change and Potential Market Catalysts
- Madrigal Pharmaceuticals (NASDAQ:MDGL) Jumps on Priority Review Status
- Madrigal announces NDA acceptance, priority review of NDA for resmetirom
- Madrigal Pharmaceuticals Announces NDA Acceptance and Priority Review of the New Drug Application for Resmetirom for the Treatment of NASH with Liver Fibrosis